We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
+17.72%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$18.5B
AUM Growth
+$1.14B
(+6.5%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-7.2%
Top 10 Holdings %
Top 10 Hldgs %
39.28%
Holding
503
New
42
Increased
140
Reduced
229
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$91.1M |
| 2 |
Advanced Micro Devices
AMD
|
+$86.6M |
| 3 |
Broadcom
AVGO
|
+$78.2M |
| 4 |
Vertiv
VRT
|
+$76.7M |
| 5 |
Burlington
BURL
|
+$42.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$142M |
| 2 |
Trip.com Group
TCOM
|
+$101M |
| 3 |
Tesla
TSLA
|
+$87.5M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$83.1M |
| 5 |
Trade Desk
TTD
|
+$80.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.38% |
| 2 | Healthcare | 19.58% |
| 3 | Consumer Discretionary | 11.08% |
| 4 | Industrials | 10.46% |
| 5 | Communication Services | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Arcus Biosciences
RCUS
$3.55B
| $1.44M | 0.01% |
75,187
-781
| -1% | -$12.5K |
|
352
Carlyle Group
CG
$16.3B
| $1.43M | 0.01% |
35,185
-1,511
| -4% | -$49.8K |
|
353
Guardant Health
GH
$20.2B
| $1.39M | 0.01% |
51,316
-508
| -1% | -$13.3K |
|
354
Palo Alto Networks
PANW
$265B
| $1.35M | 0.01% |
9,138
-133,844
| -94% | -$17.9M |
|
355
PENN Entertainment
PENN
$2.75B
| $1.33M | 0.01% |
51,100
-25,135
| -33% | -$583K |
|
356
Codexis
CDXS
$159M
| $1.32M | 0.01% |
+432,989
| New | +$930K |
|
357
Abercrombie & Fitch
ANF
$4.45B
| $1.31M | 0.01% |
+14,835
| New | +$1.06M |
|
358
Flex
FLEX
$41B
| $1.3M | 0.01% |
56,480
-13,542
| -19% | -$271K |
|
359
GSK
GSK
$104B
| $1.26M | 0.01% |
33,989
+2,398
| +8% | +$86.1K |
|
360
Newmont
NEM
$101B
| $1.25M | 0.01% |
30,096
-1,062
| -3% | -$41K |
|
361
Prothena Corp
PRTA
$440M
| $1.23M | 0.01% |
+33,724
| New | +$1.3M |
|
362
Ionis Pharmaceuticals
IONS
$8.85B
| $1.22M | 0.01% |
24,054
+10,488
| +77% | +$502K |
|
363
Arrowhead Research
ARWR
$12.3B
| $1.18M | 0.01% |
38,636
-7,783
| -17% | -$207K |
|
364
Dow Inc
DOW
$21.7B
| $1.17M | 0.01% |
21,360
+202
| +1% | +$10.3K |
|
365
Quanterix
QTRX
$166M
| $1.15M | 0.01% |
+42,006
| New | +$989K |
|
366
Kenvue
KVUE
$37.1B
| $1.12M | 0.01% |
51,880
+6,660
| +15% | +$133K |
|
367
Twist Bioscience
TWST
$5.69B
| $1.08M | 0.01% |
+29,247
| New | +$676K |
|
368
Pinduoduo
PDD
$124B
| $1.01M | 0.01% |
6,900
-600
| -8% | -$72.8K |
|
369
Neurocrine Biosciences
NBIX
$18.7B
| $967K | 0.01% |
7,339
-82,599
| -92% | -$9.51M |
|
370
Doximity
DOCS
$3.82B
| $951K | 0.01% |
33,919
-353
| -1% | -$8.34K |
|
371
Seacoast Banking Corp of Florida
SBCF
$3.35B
| $935K | 0.01% |
32,842
-76,634
| -70% | -$1.8M |
|
372
Zoetis
ZTS
$31.9B
| $885K | ﹤0.01% |
4,484
-6,898
| -61% | -$1.22M |
|
373
American Express
AXP
$228B
| $862K | ﹤0.01% |
4,600
| – | – |
|
|
JBIO
374
Jade Biosciences
JBIO
$1.22B
| $825K | ﹤0.01% |
1,042
+335
| +47% | +$171K |
|
375
Autodesk
ADSK
$49.6B
| $775K | ﹤0.01% |
3,184
| – | – |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q4 2023 Portfolio in Review
As of Q4 2023, Fred Alger Management held 503 positions worth $18.5B, up 6.5% from $17.4B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Fred Alger Management withdrew a net $1.33B in Q4 2023, closing 60 positions and reducing 229 holdings. Its most notable exit was Albemarle, an estimated $77.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 37% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Fred Alger Management opened a new position in Micron Technology worth $35.6M.
- Fred Alger Management's largest Q4 2023 buy was Micron Technology: 417,196 shares worth $35.6M.
- Fred Alger Management added most to Amgen in Q4 2023, an estimated $91.1M increase.
- Fred Alger Management's biggest Q4 2023 reduction was NVIDIA, cutting an estimated $142M.
- Fred Alger Management fully exited Albemarle in Q4 2023, selling an estimated $77.2M.
- Fred Alger Management's ten largest holdings make up 39% of its $18.5B portfolio in Q4 2023.
- Fred Alger Management opened 42 new positions and closed 60 in Q4 2023.
- Fred Alger Management's portfolio value rose 6.5% quarter-over-quarter to $18.5B.
Based on Fred Alger Management's 13F filing for Q4 2023, filed 14 Feb 2024.